Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Margaret Soucheray

7PUBLICATIONS
260CO-AUTHORS
Haematological tumoursInnate immunityMolecular targetsCancer cell biologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Feb 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells.

Ujjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar

|Sep 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.

Kelsey M Haas, Michael J McGregor, Mehdi Bouhaddou

|Sep 30, 2021
A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.

Danielle L Swaney, Dana J Ramms, Zhiyong Wang

|Sep 30, 2021
A protein interaction landscape of breast cancer.

Minkyu Kim, Jisoo Park, Mehdi Bouhaddou

|Oct 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

David E Gordon, Joseph Hiatt, Mehdi Bouhaddou

|Aug 05, 2020
Endothelin-1-Mediated Drug Resistance in <i>EGFR</i>-Mutant Non-Small Cell Lung Carcinoma.

Inés Pulido, Stephen Ollosi, Salvador Aparisi

Pageof 2

Frequent Collaborators

6 joint publications

Nevan J Krogan

6 joint publications

Danielle L Swaney

5 joint publications

Mehdi Bouhaddou

5 joint publications

Michael McGregor

4 joint publications

Hannes Braberg

4 joint publications

Manon Eckhardt

4 joint publications

Trey Ideker

4 joint publications

Kelsey M Haas

3 joint publications

Paige Haas

3 joint publications

Tia A Tummino

Frequent Collaborators

6 joint publications

Nevan J Krogan

6 joint publications

Danielle L Swaney

5 joint publications

Mehdi Bouhaddou

5 joint publications

Michael McGregor

Top Related Videos

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication
10:12

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication

Published on : Jun 14, 2024

2.0K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on : Jan 20, 2017

9.9K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.3K
See more related videos

Top Related Videos

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication
10:12

Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication

Published on : Jun 14, 2024

2.0K
Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on : Jan 20, 2017

9.9K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.3K
See more related videos